Interview | Dr. Jordi Casanellas, Director of AI at Bayer Pharma | Artificial Intelligence in Berlin
“Berlin's vibrant healthtech and AI ecosystem is a crucial component of Bayer's success”
“Berlin's vibrant healthtech and AI ecosystem is a crucial component of Bayer's success”
Vaccination as from the 22nd week of pregnancy can save lives worldwide
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In “Molecular Therapy,” a team led by Armin Rehm presents an improved immunotherapy that recognizes two distinct features of malignant…
Start of the Einstein Center for Early Disease Interception
In its December meeting, the Board of the Einstein Foundation Berlin approved new research projects with a total funding of 13 million euros over the next six years.
Deadline: 13th February 2026
ProBioGen announced today the signing of a Master Service Agreement ("MSA") with Zag Bio, Inc., a biotechnology company developing thymus-targeted therapies to induce central immune tolerance.
Surprisingly, unmodified mRNA does not trigger an inflammatory response in T cells
Deadline: Februrary 1st 2026
Karen Christman, a Stiftung Charité Visiting Fellow at the Max Delbrück Center, is among the first researchers to have won a Humboldt Research Award under Germany’s Global Minds Initiative. The award will enable her to expand her research in Germany…